The medical devices industry continues to be a hotbed of innovation. Activity is driven by increased need for homecare, preventative treatments, early diagnosis, reducing patient recovery times and improving outcomes, and a growing importance in technologies such as machine learning, augmented reality, 5G and Digitalisation. In the last three years alone, there have been over 450,000 patents filed and granted in the medical devices industry, according to GlobalData’s report on Artificial Intelligence in Healthcare: Drug delivery device security. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s Technology Foresights, which uses over 443,000 patents to analyse innovation intensity for the healthcare industry, there are 200+ innovation areas that will shape the future of the industry.
Drug delivery device security is a key innovation area in artificial intelligence
See Also:
Medical devices are increasingly being connected to the Internet, hospital networks, and other medical equipment in order to provide features that improve healthcare and increase the ability of medical practitioners to treat patients. These similar traits enhance potential cybersecurity vulnerabilities. Medical equipment, like other computer systems, are prone to security weaknesses that could endanger their use and safety.
Medication delivery device security is the use of methods and tools to prevent hackers from taking over drug delivery systems and the data they generate.
GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 20+ companies, spanning technology vendors, established healthcare companies, and up-and-coming start-ups engaged in the development and application of drug delivery device security.
Key players in drug delivery device security – a disruptive innovation in the healthcare industry
‘Application diversity’ measures the number of different applications identified for each relevant patent. It broadly splits companies into either ‘niche’ or ‘diversified’ innovators.
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in. It reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.
Patent volumes related to drug delivery device security
| Company | Total patents (2010 - 2022) | Premium intelligence on the world's largest companies |
| Johnson & Johnson | 97 | Unlock Company Profile |
| DEKA Research and Development | 69 | Unlock Company Profile |
| adidas | 56 | Unlock Company Profile |
| DexCom | 46 | Unlock Company Profile |
| Fresenius & Co | 45 | Unlock Company Profile |
| Sony Group | 42 | Unlock Company Profile |
| Samsung Group | 31 | Unlock Company Profile |
| VSP Vision | 31 | Unlock Company Profile |
| Technikka Conexion | 31 | Unlock Company Profile |
| Alphabet | 14 | Unlock Company Profile |
| Pear Therapeutics | 12 | Unlock Company Profile |
| DNAnudge | 11 | Unlock Company Profile |
| POPS! Diabetes Care | 8 | Unlock Company Profile |
| CMR Surgical | 7 | Unlock Company Profile |
| ICU Medical | 6 | Unlock Company Profile |
| Panasonic | 6 | Unlock Company Profile |
| Prevayl | 6 | Unlock Company Profile |
| PharmaSecure | 6 | Unlock Company Profile |
| SoftBank Group | 6 | Unlock Company Profile |
| Qualcomm | 6 | Unlock Company Profile |
| Otsuka Holdings | 6 | Unlock Company Profile |
| Surgicalfety Technologies | 6 | Unlock Company Profile |
| West Affum Holdings | 5 | Unlock Company Profile |
| Loewenstein Medical Technology | 5 | Unlock Company Profile |
Source: GlobalData Patent Analytics
Johnson & Johnson is the leading patent filer in the drug delivery device security market. Some other leading patent filers include DEKA Research and Development and adidas.
In terms of application diversity, Johnson & Johnson leads, followed by VSP Vision and Technikka Conexion. With regards to geographic reach, DEKA Research and Development leads, followed by DNAnudge and Johnson & Johnson.
Removing threats and vulnerabilities is challenging and reducing cybersecurity risks is extremely challenging. Given the complexity of the healthcare sector, a collaboration between manufacturers, hospitals, and facilities is necessary to reduce cybersecurity concerns.
To further understand how artificial intelligence is disrupting the healthcare industry, access GlobalData’s latest thematic research report on Artificial Intelligence (AI) in Healthcare.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Patent Analytics tracks patent filings and grants from official offices around the world. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
